More Than a Ranking

Novartis Institutes for BioMedical Research Scientists Rankings 2024

The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and Universities Rankings 2024 (Sort by: Last 6 years H Index). Click here for individual or institutional registration.

Country

Total 588 scientist

List without CERN, Statistical Data etc.

Sort by last 6 years H Index

James Bradner

Best Scientist in University/Institution

Novartis Institutes for BioMedical Research

United States

Engineering & Technology / Biomedical Engineering

Chemical Biology

Chromatin Biology

Cancer Biology

Targeted Protein Degradation

Drug Discovery

H-Index Rankings

University / Institution:

# 1

Country:

# 1,573

Region:

# 1,689

World:

# 3,423

H-Index

Total:

126

Last 6 Year:

100

Last 6 Year/Total:

0.794

i10 Index

Total:

309

Last 6 Year:

286

Last 6 Year/Total:

0.926

Citation

Total:

69,252

Last 6 Year:

38,901

Last 6 Year/Total:

0.562

Ronenn Roubenoff

Novartis Institutes for BioMedical Research

United States

Medical and Health Sciences / Rheumatology

rheumatology

muscle

sarcopenia

aging

mobility

H-Index Rankings

University / Institution:

# 2

Country:

# 2,978

Region:

# 3,219

World:

# 6,387

H-Index

Total:

108

Last 6 Year:

Last 6 Year/Total:

0.556

i10 Index

Total:

235

Last 6 Year:

156

Last 6 Year/Total:

0.664

Citation

Total:

48,656

Last 6 Year:

13,271

Last 6 Year/Total:

0.273

Richard Siegel

Novartis Institutes for BioMedical Research

United States

Medical and Health Sciences / Immunology

immunology

autoimmunity

H-Index Rankings

University / Institution:

# 3

Country:

# 9,516

Region:

# 10,455

World:

# 21,786

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.636

i10 Index

Total:

158

Last 6 Year:

125

Last 6 Year/Total:

0.791

Citation

Total:

25,668

Last 6 Year:

9,461

Last 6 Year/Total:

0.369

Pascal Furet

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Chemical Sciences

Molecular modeling and computational chemistry applied to the design of drug candidates

medicinal chemistry

H-Index Rankings

University / Institution:

# 4

Country:

# 11,293

Region:

# 12,427

World:

# 26,252

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.521

i10 Index

Total:

190

Last 6 Year:

110

Last 6 Year/Total:

0.579

Citation

Total:

19,561

Last 6 Year:

6,050

Last 6 Year/Total:

0.309

Peter Atadja

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Molecular Biology & Genetics

Epigenetics

Gene regulation

Cancer Biology

Drug discovery

Cancer translational research

H-Index Rankings

University / Institution:

# 5

Country:

# 11,304

Region:

# 12,439

World:

# 26,267

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.521

i10 Index

Total:

134

Last 6 Year:

103

Last 6 Year/Total:

0.769

Citation

Total:

20,298

Last 6 Year:

5,614

Last 6 Year/Total:

0.277

Laszlo Urban

Novartis Institutes for BioMedical Research

United States

Medical and Health Sciences / Pharmacology

secondary pharmacology

neuroscience

pharmacology

cheminformatics

safety

H-Index Rankings

University / Institution:

# 6

Country:

# 17,176

Region:

# 19,081

World:

# 41,827

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.444

i10 Index

Total:

146

Last 6 Year:

Last 6 Year/Total:

0.370

Citation

Total:

15,985

Last 6 Year:

3,096

Last 6 Year/Total:

0.194

Christian Wiesmann

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Biological Science

Drug discovery

Structural Biology

Cryo-EM

H-Index Rankings

University / Institution:

# 7

Country:

# 18,380

Region:

# 20,434

World:

# 45,213

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.639

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.781

Citation

Total:

17,406

Last 6 Year:

5,690

Last 6 Year/Total:

0.327

Frank Bretz

Novartis Institutes for BioMedical Research

United States

Others

clinical trials

multiple testing

adaptive designs

dose finding

H-Index Rankings

University / Institution:

# 8

Country:

# 19,158

Region:

# 21,318

World:

# 47,412

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.650

i10 Index

Total:

153

Last 6 Year:

Last 6 Year/Total:

0.614

Citation

Total:

30,482

Last 6 Year:

16,947

Last 6 Year/Total:

0.556

Antonio Covacci

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Molecular Biology & Genetics

molecular biology

microbiology

cell differentiation

systems biology

H-Index Rankings

University / Institution:

# 9

Country:

# 19,583

Region:

# 21,794

World:

# 48,485

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.417

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.539

Citation

Total:

22,329

Last 6 Year:

2,749

Last 6 Year/Total:

0.123

Carsten Russ

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Molecular Biology & Genetics

Genomics

H-Index Rankings

University / Institution:

# 10

Country:

# 19,762

Region:

# 21,993

World:

# 48,998

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.797

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.753

Citation

Total:

45,343

Last 6 Year:

19,282

Last 6 Year/Total:

0.425

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

Fabrice Gallou

Novartis Institutes for BioMedical Research

United States

Others

H-Index Rankings

University / Institution:

# 11

Country:

# 25,388

Region:

# 28,415

World:

# 65,453

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.906

i10 Index

Total:

131

Last 6 Year:

107

Last 6 Year/Total:

0.817

Citation

Total:

9,506

Last 6 Year:

6,678

Last 6 Year/Total:

0.703

Ricardo Dolmetsch

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Biological Science

Biology

Psychiatry

Neuroscience

Stem Cells

H-Index Rankings

University / Institution:

# 12

Country:

# 26,691

Region:

# 29,893

World:

# 69,413

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.788

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.930

Citation

Total:

22,829

Last 6 Year:

7,321

Last 6 Year/Total:

0.321

Puza P Sharma ⁱ

Novartis Institutes for BioMedical Research

United States

Medical and Health Sciences / Epidemiology and Public Health

Epidemiology

Health Economics

Outcomes Research

Cardiology

Oncology

H-Index Rankings

University / Institution:

# 13

Country:

# 26,739

Region:

# 29,947

World:

# 69,571

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.750

i10 Index

Total:

212

Last 6 Year:

133

Last 6 Year/Total:

0.627

Citation

Total:

15,752

Last 6 Year:

10,852

Last 6 Year/Total:

0.689

Matthias Schieker

Novartis Institutes for BioMedical Research

United States

Engineering & Technology / Biomedical Engineering

H-Index Rankings

University / Institution:

# 14

Country:

# 27,027

Region:

# 30,291

World:

# 70,509

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.654

i10 Index

Total:

112

Last 6 Year:

Last 6 Year/Total:

0.723

Citation

Total:

9,782

Last 6 Year:

3,888

Last 6 Year/Total:

0.397

Michele Moschetta

Novartis Institutes for BioMedical Research

United States

Others

Targeted Therapy

Immunotherapy

First in human clinical trials

H-Index Rankings

University / Institution:

# 15

Country:

# 27,827

Region:

# 31,205

World:

# 72,883

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.824

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.918

Citation

Total:

6,591

Last 6 Year:

4,691

Last 6 Year/Total:

0.712

Laszlo B Tanko

Novartis Institutes for BioMedical Research

United States

Others

Clinical research / Clinical development

H-Index Rankings

University / Institution:

# 16

Country:

# 30,092

Region:

# 33,805

World:

# 79,967

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.420

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.494

Citation

Total:

8,265

Last 6 Year:

1,463

Last 6 Year/Total:

0.177

Wei Zheng

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Molecular Biology & Genetics

computational biology

genomics

statistics

H-Index Rankings

University / Institution:

# 17

Country:

# 30,295

Region:

# 34,023

World:

# 80,591

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.857

i10 Index

Total:

129

Last 6 Year:

117

Last 6 Year/Total:

0.907

Citation

Total:

9,355

Last 6 Year:

6,053

Last 6 Year/Total:

0.647

Markus Schirle

Novartis Institutes for BioMedical Research

United States

Engineering & Technology / Biomedical Engineering

Chemical biology

Proteomics

H-Index Rankings

University / Institution:

# 18

Country:

# 31,911

Region:

# 35,869

World:

# 85,694

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.771

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.957

Citation

Total:

21,038

Last 6 Year:

7,501

Last 6 Year/Total:

0.357

Yingyao Zhou

Novartis Institutes for BioMedical Research

United States

Engineering & Technology / Computer Science

Data Science

Bio/Cheminformatics

Algorithm.

H-Index Rankings

University / Institution:

# 19

Country:

# 32,624

Region:

# 36,684

World:

# 88,106

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.542

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.671

Citation

Total:

21,694

Last 6 Year:

12,736

Last 6 Year/Total:

0.587

Andreas Clemens

Novartis Institutes for BioMedical Research

United States

Medical and Health Sciences / Endocrinology and Metabolism

Drug Development

Internal Medicine

Endocrinology

Cardiology

Diabetology

H-Index Rankings

University / Institution:

# 20

Country:

# 33,993

Region:

# 38,228

World:

# 92,524

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.574

i10 Index

Total:

105

Last 6 Year:

Last 6 Year/Total:

0.629

Citation

Total:

9,881

Last 6 Year:

2,992

Last 6 Year/Total:

0.303

Graham B Jones

Novartis Institutes for BioMedical Research

United States

Business & Management / Entrepreneurship

drug delivery

technology innovation

digital health

digital medicine

digital biomarkers

H-Index Rankings

University / Institution:

# 21

Country:

# 34,354

Region:

# 38,639

World:

# 93,534

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.426

i10 Index

Total:

219

Last 6 Year:

Last 6 Year/Total:

0.224

Citation

Total:

9,685

Last 6 Year:

2,759

Last 6 Year/Total:

0.285

John A Tallarico

Novartis Institutes for BioMedical Research

United States

Engineering & Technology / Biomedical Engineering

drug discovery

target discovery

chemical biology

novel mechanisms

novel disease associations

H-Index Rankings

University / Institution:

# 22

Country:

# 35,186

Region:

# 39,573

World:

# 96,234

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.696

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.779

Citation

Total:

9,941

Last 6 Year:

4,935

Last 6 Year/Total:

0.496

Andreas W Sailer

Novartis Institutes for BioMedical Research

United States

Others

Drug Discovery

H-Index Rankings

University / Institution:

# 23

Country:

# 36,473

Region:

# 41,034

World:

# 100,311

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.778

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.843

Citation

Total:

12,253

Last 6 Year:

3,061

Last 6 Year/Total:

0.250

Jeremy L Jenkins

Novartis Institutes for BioMedical Research

United States

Natural Sciences / Chemical Sciences

cheminformatics

phenotypic screening

target prediction

chemical biology

H-Index Rankings

University / Institution:

# 24

Country:

# 37,021

Region:

# 41,694

World:

# 102,296

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.622

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.679

Citation

Total:

9,107

Last 6 Year:

3,525

Last 6 Year/Total:

0.387

Guglielmo Roma

Novartis Institutes for BioMedical Research

United States

Others

H-Index Rankings

University / Institution:

# 25

Country:

# 41,345

Region:

# 46,625

World:

# 116,227

H-Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.929

i10 Index

Total:

Last 6 Year:

Last 6 Year/Total:

0.918

Citation

Total:

8,552

Last 6 Year:

6,441

Last 6 Year/Total:

0.753

				AD Scientific Index - World Scientists Rankings - 2024				H INDEX			i10 INDEX			CITATION
University / Institution	Country	Region	World	Name	Country	University / Institution	Subject	Total	Last 6 year	Last 6 year/total	Total	Last 6 year	Last 6 year/total	Total	Last 6 year	Last 6 year/total
1	1,573	1,689	3,423	James Bradner	United States	Novartis Institutes for BioMedical Research	Engineering & Technology / Biomedical Engineering Chemical Biology \| Chromatin Biology \| Cancer Biology \| Targeted Protein Degradation \| Drug Discovery \|	126	100	0.794	309	286	0.926	69,252	38,901	0.562
2	2,978	3,219	6,387	Ronenn Roubenoff	United States	Novartis Institutes for BioMedical Research	Medical and Health Sciences / Rheumatology rheumatology \| muscle \| sarcopenia \| aging \| mobility \|	108	60	0.556	235	156	0.664	48,656	13,271	0.273
3	9,516	10,455	21,786	Richard Siegel	United States	Novartis Institutes for BioMedical Research	Medical and Health Sciences / Immunology immunology \| autoimmunity \|	77	49	0.636	158	125	0.791	25,668	9,461	0.369
4	11,293	12,427	26,252	Pascal Furet	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Chemical Sciences Molecular modeling and computational chemistry applied to the design of drug candidates \| medicinal chemistry \|	73	38	0.521	190	110	0.579	19,561	6,050	0.309
5	11,304	12,439	26,267	Peter Atadja	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Molecular Biology & Genetics Epigenetics \| Gene regulation \| Cancer Biology \| Drug discovery \| Cancer translational research \|	73	38	0.521	134	103	0.769	20,298	5,614	0.277
6	17,176	19,081	41,827	Laszlo Urban	United States	Novartis Institutes for BioMedical Research	Medical and Health Sciences / Pharmacology secondary pharmacology \| neuroscience \| pharmacology \| cheminformatics \| safety \|	63	28	0.444	146	54	0.370	15,985	3,096	0.194
7	18,380	20,434	45,213	Christian Wiesmann	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Biological Science Drug discovery \| Structural Biology \| Cryo-EM \|	61	39	0.639	96	75	0.781	17,406	5,690	0.327
8	19,158	21,318	47,412	Frank Bretz	United States	Novartis Institutes for BioMedical Research	Others clinical trials \| multiple testing \| adaptive designs \| dose finding \|	60	39	0.650	153	94	0.614	30,482	16,947	0.556
9	19,583	21,794	48,485	Antonio Covacci	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Molecular Biology & Genetics molecular biology \| microbiology \| cell differentiation \| systems biology \|	60	25	0.417	89	48	0.539	22,329	2,749	0.123
10	19,762	21,993	48,998	Carsten Russ	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Molecular Biology & Genetics Genomics \|	59	47	0.797	97	73	0.753	45,343	19,282	0.425
			Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages
11	25,388	28,415	65,453	Fabrice Gallou	United States	Novartis Institutes for BioMedical Research	Others	53	48	0.906	131	107	0.817	9,506	6,678	0.703
12	26,691	29,893	69,413	Ricardo Dolmetsch	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Biological Science Biology \| Psychiatry \| Neuroscience \| Stem Cells \|	52	41	0.788	71	66	0.930	22,829	7,321	0.321
13	26,739	29,947	69,571	Puza P Sharma ⁱ	United States	Novartis Institutes for BioMedical Research	Medical and Health Sciences / Epidemiology and Public Health Epidemiology \| Health Economics \| Outcomes Research \| Cardiology \| Oncology \|	52	39	0.750	212	133	0.627	15,752	10,852	0.689
14	27,027	30,291	70,509	Matthias Schieker	United States	Novartis Institutes for BioMedical Research	Engineering & Technology / Biomedical Engineering	52	34	0.654	112	81	0.723	9,782	3,888	0.397
15	27,827	31,205	72,883	Michele Moschetta	United States	Novartis Institutes for BioMedical Research	Others Targeted Therapy \| Immunotherapy \| First in human clinical trials \|	51	42	0.824	85	78	0.918	6,591	4,691	0.712
16	30,092	33,805	79,967	Laszlo B Tanko	United States	Novartis Institutes for BioMedical Research	Others Clinical research / Clinical development \|	50	21	0.420	85	42	0.494	8,265	1,463	0.177
17	30,295	34,023	80,591	Wei Zheng	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Molecular Biology & Genetics computational biology \| genomics \| statistics \|	49	42	0.857	129	117	0.907	9,355	6,053	0.647
18	31,911	35,869	85,694	Markus Schirle	United States	Novartis Institutes for BioMedical Research	Engineering & Technology / Biomedical Engineering Chemical biology \| Proteomics \|	48	37	0.771	70	67	0.957	21,038	7,501	0.357
19	32,624	36,684	88,106	Yingyao Zhou	United States	Novartis Institutes for BioMedical Research	Engineering & Technology / Computer Science Data Science \| Bio/Cheminformatics \| Algorithm. \|	48	26	0.542	73	49	0.671	21,694	12,736	0.587
20	33,993	38,228	92,524	Andreas Clemens	United States	Novartis Institutes for BioMedical Research	Medical and Health Sciences / Endocrinology and Metabolism Drug Development \| Internal Medicine \| Endocrinology \| Cardiology \| Diabetology \|	47	27	0.574	105	66	0.629	9,881	2,992	0.303
21	34,354	38,639	93,534	Graham B Jones	United States	Novartis Institutes for BioMedical Research	Business & Management / Entrepreneurship drug delivery \| technology innovation \| digital health \| digital medicine \| digital biomarkers \|	47	20	0.426	219	49	0.224	9,685	2,759	0.285
22	35,186	39,573	96,234	John A Tallarico	United States	Novartis Institutes for BioMedical Research	Engineering & Technology / Biomedical Engineering drug discovery \| target discovery \| chemical biology \| novel mechanisms \| novel disease associations \|	46	32	0.696	68	53	0.779	9,941	4,935	0.496
23	36,473	41,034	100,311	Andreas W Sailer	United States	Novartis Institutes for BioMedical Research	Others Drug Discovery \|	45	35	0.778	70	59	0.843	12,253	3,061	0.250
24	37,021	41,694	102,296	Jeremy L Jenkins	United States	Novartis Institutes for BioMedical Research	Natural Sciences / Chemical Sciences cheminformatics \| phenotypic screening \| target prediction \| chemical biology \|	45	28	0.622	81	55	0.679	9,107	3,525	0.387
25	41,345	46,625	116,227	Guglielmo Roma	United States	Novartis Institutes for BioMedical Research	Others	42	39	0.929	73	67	0.918	8,552	6,441	0.753